Business Description
Changchun BCHT Biotechnology Co
ISIN : CNE100005XY6
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.44 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.13 | |||||
Interest Coverage | 360.41 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.98 | |||||
Beneish M-Score | -2.23 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.9 | |||||
3-Year EBITDA Growth Rate | 1.9 | |||||
3-Year EPS without NRI Growth Rate | 1.8 | |||||
3-Year FCF Growth Rate | -14.7 | |||||
3-Year Book Growth Rate | 26.7 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.14 | |||||
9-Day RSI | 43.31 | |||||
14-Day RSI | 44.98 | |||||
6-1 Month Momentum % | -7.85 | |||||
12-1 Month Momentum % | -50.38 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.04 | |||||
Quick Ratio | 1.85 | |||||
Cash Ratio | 0.26 | |||||
Days Inventory | 427.86 | |||||
Days Sales Outstanding | 350.58 | |||||
Days Payable | 37.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.57 | |||||
Dividend Payout Ratio | 0.13 | |||||
Forward Dividend Yield % | 0.57 | |||||
5-Year Yield-on-Cost % | 0.57 | |||||
3-Year Average Share Buyback Ratio | -3.6 | |||||
Shareholder Yield % | 0.48 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88.3 | |||||
Operating Margin % | 32.71 | |||||
Net Margin % | 25.77 | |||||
FCF Margin % | -10.93 | |||||
ROE % | 10.22 | |||||
ROA % | 8.16 | |||||
ROIC % | 12.16 | |||||
ROC (Joel Greenblatt) % | 15.74 | |||||
ROCE % | 11.55 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 26.09 | |||||
Forward PE Ratio | 17.39 | |||||
PE Ratio without NRI | 23.27 | |||||
Price-to-Owner-Earnings | 427.7 | |||||
PEG Ratio | 1.94 | |||||
PS Ratio | 6.75 | |||||
PB Ratio | 2.57 | |||||
Price-to-Tangible-Book | 2.79 | |||||
Price-to-Operating-Cash-Flow | 29.8 | |||||
EV-to-EBIT | 22.21 | |||||
EV-to-EBITDA | 22.21 | |||||
EV-to-Revenue | 6.51 | |||||
EV-to-FCF | -60.28 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.81 | |||||
Price-to-Graham-Number | 1.7 | |||||
Price-to-Net-Current-Asset-Value | 10.19 | |||||
Earnings Yield (Greenblatt) % | 4.5 | |||||
FCF Yield % | -1.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Changchun BCHT Biotechnology Co Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,607.507 | ||
EPS (TTM) (Â¥) | 1 | ||
Beta | 1.85 | ||
Volatility % | 51.69 | ||
14-Day RSI | 44.98 | ||
14-Day ATR (Â¥) | 0.693232 | ||
20-Day SMA (Â¥) | 26.6925 | ||
12-1 Month Momentum % | -50.38 | ||
52-Week Range (Â¥) | 21.18 - 58.5 | ||
Shares Outstanding (Mil) | 413.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Changchun BCHT Biotechnology Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Changchun BCHT Biotechnology Co Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Changchun BCHT Biotechnology Co Frequently Asked Questions
What is Changchun BCHT Biotechnology Co(SHSE:688276)'s stock price today?
When is next earnings date of Changchun BCHT Biotechnology Co(SHSE:688276)?
Does Changchun BCHT Biotechnology Co(SHSE:688276) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |